Possible postganglionic adrenergic effect of angiotensin in the isolated perfused cat intestinal segment.
D000311:Adrenal Glands / Q000502:physiology; D000315:Adrenalectomy; D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D002395:Catecholamines / Q000378:metabolism; D002415:Cats; D004336:Drug Antagonism; D004878:Ergotamine / Q000494:pharmacology; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006426:Hemicholinium 3 / Q000494:pharmacology; D006584:Hexamethonium Compounds / Q000494:pharmacology; D007082:Ileum / Q000187:drug effects* / Q000294:innervation; D008297:Male; D009538:Nicotine / Q000494:pharmacology; D010477:Perfusion; D012110:Reserpine / Q000494:pharmacology; D013153:Splanchnic Nerves / Q000187:drug effects
D002395:Catecholamines; D006584:Hexamethonium Compounds; D000804:Angiotensin II; D006426:Hemicholinium 3; D009538:Nicotine; D012110:Reserpine; D004878:Ergotamine